These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Objective evaluation of gallopamil in patients with chronic stable angina. Exercise testing, Holter monitoring, cross-sectional echocardiography and plasma levels. Scrutinio D, Lagioia R, Mangini SG, Mastropasqua F, Ricci A, Chiddo A, Rizzon P. Eur Heart J; 1989 Feb; 10(2):168-76. PubMed ID: 2647495 [Abstract] [Full Text] [Related]
6. Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine. Lazzeroni E, Morozzi L, Campana M, Botti G. Eur Heart J; 1992 Apr; 13(4):526-30. PubMed ID: 1600993 [Abstract] [Full Text] [Related]
8. Age-response effectiveness of gallopamil for the treatment of myocardial exertional ischemia. A medium-term randomized cross-over double-blind placebo-controlled trial. Acanfora D, Odierna L, De Caprio L, Longobardi G, Rengo C, Guerra N, Furgi G, Bollella OF, Picone C, Rengo F. Aging (Milano); 1995 Apr; 7(2):150-6. PubMed ID: 7548266 [Abstract] [Full Text] [Related]
9. [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study]. Rettig G, Sen S, Schieffer H, Bette L. Z Kardiol; 1983 Dec; 72(12):746-54. PubMed ID: 6421002 [Abstract] [Full Text] [Related]
10. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris. Carboni GP, Saltarocchi ML, Risa AL, Scardovi AB, Zanchi E, Prati PL. J Cardiovasc Pharmacol; 1992 Dec; 20 Suppl 7():S64-70. PubMed ID: 1284159 [Abstract] [Full Text] [Related]
11. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. Hopf R, Drews H, Kaltenbach M. Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005 [Abstract] [Full Text] [Related]
14. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo]. Loskot F, Novotny P, Sucic P, Schneider G. Z Kardiol; 1989 Sep; 78 Suppl 5():89-93. PubMed ID: 2698569 [Abstract] [Full Text] [Related]
15. [An ergometric cross-over evaluation of the anti-ischemic efficacy of amlodipine and gallopamil in stable angina of effort]. Perticone F, Borelli DA, Pugliese F, Maio R, Costa R, Cosco C, Ceravolo R, Mattioli PL. Cardiologia; 1993 Jul; 38(7):455-62. PubMed ID: 8221740 [Abstract] [Full Text] [Related]
18. [Acute effects of transdermal administration of nitroglycerin on effort tolerance and myocardial perfusion, evaluated by Tl-201 scintigraphy, in patients with stable effort angina]. Novo S, Liquori M, Abrignani MG, Giuliano F, Panno V, Fazio M, Adamo L, Corda M, Indovina A, di Maria G. Cardiologia; 1991 Sep; 36(9):693-702. PubMed ID: 1802393 [Abstract] [Full Text] [Related]
19. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Thadani U, Ezekowitz M, Fenney L, Chiang YK. Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941 [Abstract] [Full Text] [Related]
20. Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris. Vilchez FG, Villarroel T, Ruano Calvo J, Vazquez de Prada JA, Martin-Duran R, San Jose JM, Pajaron A. Int J Cardiol; 1992 Oct; 37(1):91-9. PubMed ID: 1428294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]